Digital Health Global

APRIL 15, 2024

Combined, the network helps pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, and solve unique geographic and market-specific challenges. They are, however, fully owned and operated by EVERSANA.

Life Science 88

Life Science Pharmaceuticals BioTech Digital Health 88

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years. Connect with her at [link].

BioTech 97

BioTech Life Science Drug Development Patient Experience 97

Lloyd Price

FEBRUARY 23, 2025

These figures highlight its ability to grow profitably, a rarity in healthcare IT, and its dominance in the digital physician market, which it expects to expand 5-7% annually, with Doximity aiming to outpace that. Comparatively, the healthcare sector has lagged in recent years, but 2025 is showing signs of a turnaround. Subscribe Today!

Telehealth 76

Telehealth Leadership Digital Health BioTech 76

Digital Health

FEBRUARY 3, 2020

After escaping the revolution in Iran, Sean Khozin found his way to the United States, harmonizing his passion for patients and data into a career that’s led him into startups, the FDA, and most recently J&J, where he’s now Global Head of Data Strategy – all while pursuing his love of music. The phrase “it’s […].

BioTech 360

BioTech Pharmaceuticals Digital Health 360

Digital Health Global

AUGUST 30, 2023

QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners. We are very pleased to co-invest in QuantHealth alongside Pitango and to further expand our growth unit Bertelsmann Next with an investment focus on Digital Health,” said Thorsten Wirkes at Bertelsmann Investments.

BioTech 88

BioTech Drug Development Life Science Pharmaceuticals 88

Digital Health Global

JUNE 20, 2023

Dr. Rhodes brings more than 25 years of drug discovery, company building and strategic leadership in the biotech industry, including 18 years at Biogen. Based on her work in the digital health space, she co-founded Qr8 Health, a software development company pioneering the development of clinically validated patient assessment tools.

BioTech 88

BioTech Life Science Leadership Drug Development 88

Digital Health Global

AUGUST 2, 2023

Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He Colin is a proven leader with a deep understanding of the digital health technology industry. Colin has demonstrated strong leadership to his teams and customers alike.” “I

BioTech 88

BioTech Digital Health Pharmaceuticals healthcare technology 88

Digital Health Global

MARCH 1, 2023

With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie’s leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. Mundipharma is a global pharmaceutical leader. Tanda, Aptar President and CEO.

Pharmaceuticals 68

Pharmaceuticals Leadership BioTech Digital Health 68

Digital Health Global

FEBRUARY 5, 2024

About Solas BioVentures Solas BioVentures invests exclusively in the life science industry, focusing on early-stage biotech, medtech and digital health companies. This strategy has been validated through a number of companies in both Fund I and II and the Colucid Pharmaceuticals exit.

Life Science 88

Life Science Pharmaceuticals Medical Technology BioTech 88

Lloyd Price

JANUARY 10, 2019

Click here to download a copy of the report Asia HealthTech closed the year at a record breaking US$6.3B, confirming it as the 2nd largest digital health ecosystem in the world. HealthTech defines the intersection between healthcare and technology and is also sometimes referred to as digital health. Source : [link]

BioTech 58

BioTech Pharmaceuticals Digital Health 58

Digital Health Global

MARCH 16, 2023

Both Wellington and Forbion are visionaries and highly experienced biotech investors, and we look forward to working closely with them in our efforts to transform the gene editing landscape.” “Our Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space. With funds totaling more than €1.2

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Digital Health Global

FEBRUARY 20, 2024

About MRM Health MRM Health is a clinical-stage biotech developing innovative therapeutics for inflammatory, CNS and metabolic diseases. The SIMBA capsule was developed and validated by Nimble Science and has already shown its promise in retrieving specific small intestine material in previous studies.

BioTech 88

BioTech Pharmaceuticals Digital Health Health Data 88

Lloyd Price

SEPTEMBER 30, 2024

Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Why Healthcare? Subscribe Today! Subscribe Today!

BioTech 57

BioTech Pharmaceuticals Leadership healthcare technology 57

Digital Health Global

SEPTEMBER 27, 2023

Lodo Therapeutics (acquired by Zymergen, now Ginkgo BioWorks), Petra Pharma (acquired by a global pharmaceutical company), Proniras Corporation, and Rodeo Therapeutics (acquired by Amgen Inc.). About ClavystBio ClavystBio’s mission is to accelerate the commercialization of life science breakthroughs into health impact.

Life Science 88

Life Science Drug Development HC BioTech 88

Digital Health Global

JANUARY 30, 2023

About Mark Cuban Cost Plus Drug Company The Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) aims to fundamentally change the way the pharmaceutical industry operates. As a public-benefit corporation, its social mission of improving public health is just as important as the bottom line.

BioTech 68

BioTech Pharmaceuticals Digital Health Public Health 68

Healthcare IT Today

AUGUST 1, 2023

About Parker Health Parker Health is a multinational Mexican-American-founded and minority-led biotechnology company determined to advance healthcare and technology into the next century. A member of the Sequoia Project, Parker Health is dual headquartered in Washington, DC and Dallas, TX, with offices in Menlo Park, CA.

BioTech 52

BioTech FHIR Pharmaceuticals Interoperability 52

Digital Health Global

JUNE 20, 2023

With this fundraising, BrainTale aims to provide physicians and pharmaceutical companies with innovative solutions to improve the diagnosis, monitoring and prediction of neurological diseases and disorders, in particular Alzheimer’s and Parkinson’s disease, amyotrophic lateral sclerosis and traumatic brain injury.

Life Science 88

Life Science Drug Development BioTech Pharmaceuticals 88

Lloyd Price

SEPTEMBER 2, 2023

The key trends that are expected to shape the market in 2023 include: Increased focus on digital health: Healthcare companies are increasingly looking to acquire digital health businesses in order to improve their offerings and stay ahead of the competition. Engage with the HealthTech Community Thoughts, comments?

Life Science 67

Life Science Digital Health EHR BioTech 67

Lloyd Price

FEBRUARY 13, 2024

Exec Summary: Scotland has emerged as a global leader in the field of digital health and care, driven by a combination of factors: A strong foundation in medical innovation: Scotland boasts a rich history of medical breakthroughs, from the world's first cloned sheep (Dolly) to pioneering research in stem cell therapy.

Healthcare Innovation 67

Healthcare Innovation Digital Health Life Science healthcare technology 67

Lloyd Price

SEPTEMBER 16, 2023

The top three sectors for investment were: Digital health (£244 million) Therapeutics (£225 million) Medtech (£136 million) Some of the notable deals in 2022 included: Amphista Therapeutics (£38 million) Resolution Therapeutics (£34 million) ODx (£7.6 1) Pioneering healthcare: Scotland has a long history of pioneering healthcare.

Life Science 70

Life Science Digital Health BioTech Health Technology 70

Digital Health Today

DECEMBER 11, 2019

My name is Rachel Francine and I am the co-founder and CEO of musical health technologies, we created a digital health platform, Singfit. Carrie: Tell me a little bit about yourself and what brings you to the Connected Health Conference? And there aren’t a lot of investors who focus on digital health.

Health Technology 52

Health Technology Digital Health Connected Health BioTech 52

Digital Health Today

NOVEMBER 28, 2023

This unparalleled gathering of healthcare and biotech leaders showcases the enduring power of collaboration and innovation, shaping the future of healthcare. The post JPM Healthcare Conference 2024 appeared first on Digital Health Today. Many of these are accessible to the public, but most require registration in advance.

Life Science 52

Life Science BioTech Pharmaceuticals Healthcare Innovation 52

Lloyd Price

FEBRUARY 24, 2019

One of the biggest challenges involves efficiently achieving validations of digital health devices and smartphone apps – that is, ensuring the intended use of a medical device and the management of its data. Loetitia Jabri is regulatory, pharmaceutical & medical devices platforms associate director at ProductLife Group.

Life Science 51

Life Science BioTech Mobile Health Solutions Pharmaceuticals 51

Digital Health Global

MAY 8, 2023

BPS has long been recognized worldwide as a trusted and preferred partner of contract manufacturing services for the pharmaceutical and biotech industries. The firm has completed over 50 investments in 17 countries worldwide across a range of sub-sectors, including pharmaceuticals, life sciences and medical devices.

Pharmaceuticals 88

Pharmaceuticals Life Science BioTech Leadership 88

Health Populi

JULY 1, 2019

And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. When this occurred, it didn’t cause more than a ripple of interest outside biotech. But the U.S. citizens’ personal data.

Pharmaceuticals 216

Pharmaceuticals HIPAA BioTech Patient Experience 216

Lloyd Price

FEBRUARY 7, 2025

Exec Summary: The digital health IPO boom of 2021 saw a surge of companies entering the public market, but the landscape has shifted since then. Why did so many Digital Health companies go public in 2021? There were a confluence of factors that fueled the surge of digital health companies going public in 2021: 1.

Digital Health 70

Digital Health healthcare technology Primary Care Telehealth 70

Lloyd Price

JUNE 22, 2024

Exec Summary: The digital health IPO boom of 2021 saw a surge of companies entering the public market, but the landscape has shifted since then. Why did so many Digital Health companies go public in 2021? There were a confluence of factors that fueled the surge of digital health companies going public in 2021: 1.

Digital Health 70

Digital Health healthcare technology Primary Care Telehealth 70

Health Populi

JANUARY 9, 2020

Several consumer surveys published to coincide with CES 2020 provide insights into the new consumer trust mindset across industries, but especially important for health engagement. The Digital Health Summit at CES collaborated with Kantar on a poll gauging peoples’ perspectives on trust , technology and health.

BioTech 177

BioTech Pharmaceuticals Digital Health Nursing 177

Health Populi

MARCH 13, 2018

Specifically, $19 billion worth of biotech spending will find biosimilar competition starting in 2018 for the first time. The report pointed especially to hospital and pharmaceutical prices.

Telehealth 168

Telehealth Pharmaceuticals BioTech Medicare 168

Health Populi

JULY 2, 2018

Most Americans say that pharmaceutical manufacturers, banks, advertisers, energy firms, and tech companies have too much power and influence in today’s American economy, according to Public Attitudes Toward Technology Companies , a research report from the Pew Research Center.

BioTech 120

BioTech Pharmaceuticals Health Data Telehealth 120

Health Populi

MAY 19, 2019

.” Health Populi’s Hot Points: RealClear asked people to consult their forecasting tea leaves to consider which industries and organizations would improve the quality of health care for Americans 20 years into the future.

Life Science 159

Life Science BioTech Medicare Medical Billing 159